122 related articles for article (PubMed ID: 10481738)
1. Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease.
Takahashi K; Ohta Y; Kanai K; Akahane Y; Iwasa Y; Hino K; Ohno N; Yoshizawa H; Mishiro S
Arch Virol; 1999; 144(7):1299-308. PubMed ID: 10481738
[TBL] [Abstract][Full Text] [Related]
2. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
[TBL] [Abstract][Full Text] [Related]
3. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.
Tanaka Y; Mukaide M; Orito E; Yuen MF; Ito K; Kurbanov F; Sugauchi F; Asahina Y; Izumi N; Kato M; Lai CL; Ueda R; Mizokami M
J Hepatol; 2006 Nov; 45(5):646-53. PubMed ID: 16935384
[TBL] [Abstract][Full Text] [Related]
4. T1653 mutation in the enhancer II region of the hepatitis B virus genome in southern African Blacks with hepatocellular carcinoma.
Welschinger R; Kew MC; Viana R; Badri M
Eur J Gastroenterol Hepatol; 2010 May; 22(5):541-5. PubMed ID: 20173647
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
Shinkai N; Tanaka Y; Ito K; Mukaide M; Hasegawa I; Asahina Y; Izumi N; Yatsuhashi H; Orito E; Joh T; Mizokami M
J Clin Microbiol; 2007 Oct; 45(10):3191-7. PubMed ID: 17652471
[TBL] [Abstract][Full Text] [Related]
6. [Study on the distribution of hepatitis B virus precore and basic core promoter mutations in Guizhou area].
Ding JJ; Liu YH; Wang M
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Feb; 28(2):169-72. PubMed ID: 17649690
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
[TBL] [Abstract][Full Text] [Related]
8. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
[TBL] [Abstract][Full Text] [Related]
9. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
[TBL] [Abstract][Full Text] [Related]
10. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
[TBL] [Abstract][Full Text] [Related]
11. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
[TBL] [Abstract][Full Text] [Related]
12. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
[TBL] [Abstract][Full Text] [Related]
13. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
15. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
[TBL] [Abstract][Full Text] [Related]
16. The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.
Tsai MC; Chen CH; Lee CM; Chen YT; Chien YS; Hung CH; Wang JH; Lu SN; Yen YH; Changchien CS; Hu TH
J Hepatol; 2009 Feb; 50(2):281-8. PubMed ID: 19070392
[TBL] [Abstract][Full Text] [Related]
17. Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients.
Truong BX; Yano Y; Seo Y; Phuong TM; Tanaka Y; Kato H; Miki A; Utsumi T; Azuma T; Trach NK; Mizokami M; Hayashi Y; Kasuga M
J Med Virol; 2007 Sep; 79(9):1293-304. PubMed ID: 17607788
[TBL] [Abstract][Full Text] [Related]
18. T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients.
Hou J; Lau GK; Cheng J; Cheng CC; Luo K; Carman WF
Liver; 1999 Oct; 19(5):411-7. PubMed ID: 10533799
[TBL] [Abstract][Full Text] [Related]
19. X gene mutations in hepatitis B patients with cirrhosis, with and without hepatocellular carcinoma.
Choi CS; Cho EY; Park R; Kim SJ; Cho JH; Kim HC
J Med Virol; 2009 Oct; 81(10):1721-5. PubMed ID: 19697408
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
